BHC BAUSCH HEALTH COMPANIES INC Investments/Divestments 8-K Filing 2023 - Secured Notes Offering Bausch + Lomb, a subsidiary of Bausch Health Companies Inc., completed a $1.4 billion secured notes offering to fund the acquisition of XIIDRA and other ophthalmology assets from Novartis.Get access to all SEC 8-K filings of the BAUSCH HEALTH COMPANIES INC